Merit Medical Systems (MMSI) Research & Development (2010 - 2026)

Merit Medical Systems has disclosed Research & Development across 17 years of filings, most recently posting $22.6 million for Q1 2026.

• Research & Development for Q1 2026 came in at $22.6 million, up 0.58% year-over-year; the trailing twelve-month figure through Mar 2026 was $97.5 million (up 10.2% YoY), and the FY2025 annual result was $97.4 million, up 11.3% from the prior year.
• Research & Development came in at $22.6 million for Q1 2026 at Merit Medical Systems, down from $26.5 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $26.5 million in Q4 2025 to a low of $17.4 million in Q1 2022.
• The 5-year median for Research & Development is $21.3 million (2023), against an average of $21.5 million.
• Across the five-year window, Research & Development gained 0.15% in 2022 and climbed 22.59% in 2023, its largest moves.
• Merit Medical Systems' Research & Development stood at $20.4 million in 2022, then grew by 5.89% to $21.6 million in 2023, then advanced by 16.43% to $25.2 million in 2024, then grew by 5.35% to $26.5 million in 2025, then decreased by 14.81% to $22.6 million in 2026.
• The last three Research & Development figures came in at $22.6 million (Q1 2026), $26.5 million (Q4 2025), and $24.0 million (Q3 2025), per Business Quant data.